(Total Views: 373)
Posted On: 07/04/2019 6:36:51 PM
Post# of 150716
Very funny! I’m trying to wean myself of the cydy board on iHub. I’m okay with shareholders complaining, they have earned the right, but I don’t like non-shareholders who clearly follow every word going out of the company but then try to convince shareholders it is going to fail. They wouldn’t waste their time if they really thought that; just trying to pick up cheap shares. Let me guess, this person is calling for 30c.
Also, I guess the next username to pop up will be Johann Sebastian.
On a note on the md recruiting for the tnbc clinical trial. Read her bio to see if you think this person would have a sense of urgency.
Milana V. Dolezal, M.D., M.Sci
"My passion for cancer research started as a teenager working at the National Cancer Institute, NIH in Bethesda, MD where I am from. My compassion for people with cancer came from taking care of my Grandma who helped raise me and died from metastatic breast cancer in our home. Through training at UCLA and then clinical trial work at Genentech, I've witnessed the translation of targeted cancer therapies from bench to bedside. I was fortunate enough to ride my bike across the USA to promote patient participation in clinical trials which help develop new treatments. I provide personalized care by targeting the tumor biology and working with patient and their support team to find the best treatment. I believe in a multidisciplinary approach, including clinical trials if appropriate, and tumor board review. My special interests include women's malignancies and cancer survivorship. Courage and hope exist in all of us: the patient's determination and full participation is crucial".
Also, I guess the next username to pop up will be Johann Sebastian.
On a note on the md recruiting for the tnbc clinical trial. Read her bio to see if you think this person would have a sense of urgency.
Milana V. Dolezal, M.D., M.Sci
"My passion for cancer research started as a teenager working at the National Cancer Institute, NIH in Bethesda, MD where I am from. My compassion for people with cancer came from taking care of my Grandma who helped raise me and died from metastatic breast cancer in our home. Through training at UCLA and then clinical trial work at Genentech, I've witnessed the translation of targeted cancer therapies from bench to bedside. I was fortunate enough to ride my bike across the USA to promote patient participation in clinical trials which help develop new treatments. I provide personalized care by targeting the tumor biology and working with patient and their support team to find the best treatment. I believe in a multidisciplinary approach, including clinical trials if appropriate, and tumor board review. My special interests include women's malignancies and cancer survivorship. Courage and hope exist in all of us: the patient's determination and full participation is crucial".
(1)
(0)Scroll down for more posts ▼
